feed,title,long_url,short_url
Benzinga,FDA Approves Myovant Sciences/Pfizer's Treatment For Endometriosis-Associated Pain,https://benzinga.com/general/biotech/22/08/28391899/fda-approves-myovant-sciencespfizers-treatment-for-endometriosis-associated-pain,https://bit.ly/3A5EXVa
Benzinga,Radware Misses On Q2 As Macro Headwinds Led To Delays In Deal Closures; Clocks 8% Revenue Growth,https://benzinga.com/news/earnings/22/08/28392583/radware-misses-q2-as-the-macro-headwinds-led-to-delays-in-deal-closures-clocks-8-revenue-growth,https://bit.ly/3Q3F60K
